Backbone assignment of E. coli NfsB and the effects of addition of the cofactor analogue nicotinic acid
E. coli nitroreductase NfsB (also called NfnB) has been studied extensively, largely due to its potential for cancer gene therapy. A homodimeric flavoprotein of 216 residues, it catalyses the reduction of nitroaromatics to cytotoxic hydroxylamines by NADH and NADPH and also the reduction of quinones...
Main Authors: | Hyde, EI, Chau, AK-W, Smith, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2021
|
Similar Items
-
Functional and Structural Characterization of Diverse NfsB Chloramphenicol Reductase Enzymes from Human Pathogens
by: Michael W. Mullowney, et al.
Published: (2022-04-01) -
A genetically engineered Escherichia coli strain overexpressing the nitroreductase NfsB is capable of producing the herbicide D-DIBOA with 100% molar yield
by: Maria Elena de la Calle, et al.
Published: (2019-05-01) -
Use of <it>nfsB</it>, encoding nitroreductase, as a reporter gene to determine the mutational spectrum of spontaneous mutations in <it>Neisseria gonorrhoeae</it>
by: Dunham Stephen, et al.
Published: (2009-11-01) -
Managing NFS and NIS/
by: Stern, Hal, et al.
Published: (1993) -
Oligonucleotide analogues with cationic backbone linkages
by: Melissa Meng, et al.
Published: (2018-06-01)